POLARITYTE, INC. (NASDAQ:COOL) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On June 8, 2017, PolarityTE, Inc. (the Company) issued a press
release which provides information with respect to pre-clinical
results.
A copy of the press release is filed as Exhibit 99.1 to this
Current Report and is incorporated by reference herein. The
information in this Current Report is being furnished and shall
not be deemed filed for the purposes of Section 18 of the
Exchange Act or otherwise subject to the liabilities of that
section. The information in this Current Report shall not be
incorporated by reference into any registration statement or
other document to the Securities Act, except as shall be
expressly set forth by specific reference in any such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit | Description of Exhibit | |
| 99.1 | Press release dated June 8, 2017 |
About POLARITYTE, INC. (NASDAQ:COOL)
PolarityTE, Inc., formerly Majesco Entertainment Company, is a technology company. The Company has developed, marketed, published and distributed software through online platforms. The Company develops applications for gaming on computers, handheld devices and game consoles. The Company is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. It seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Its PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. Its platform induces cell and tissue polarity, and creates functional tissue that mirrors natural development in the human body.
